Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy
Mohammad Mirza‐Aghazadeh‐Attari, Elyad Ekrami, Seyed Ali Mousavi‐Aghdas, et al.
Life Sciences (2020) Vol. 255, pp. 117481-117481
Closed Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 3
<p>Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma</p>
Wei Han, Jia Shi, Jiachao Cao, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 6937-6955
Open Access | Times Cited: 29
Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment
Dongning Li, Jie Zhang, Xiaoyan Zhao
Cancer Investigation (2021) Vol. 39, Iss. 8, pp. 675-684
Closed Access | Times Cited: 25
Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18090-e18090
Open Access | Times Cited: 9
RETRACTED: Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib
Shahin Hallaj, Sima Heydarzadeh Asl, Fatemeh Alian, et al.
Life Sciences (2020) Vol. 259, pp. 118150-118150
Closed Access | Times Cited: 25
Molecular events in the pathogenesis of vulvar squamous cell carcinoma
Deyin Xing, Oluwole Fadare
Seminars in Diagnostic Pathology (2020) Vol. 38, Iss. 1, pp. 50-61
Open Access | Times Cited: 24
Formulation of Kaempferol in Nanostructured Lipid Carriers (NLCs): A Delivery Platform to Sensitization of MDA-MB468 Breast Cancer Cells to Paclitaxel
Toofan Aghazadeh, Nuredin Bakhtiari, Isa Abdi, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 11, Iss. 6, pp. 14591-14601
Open Access | Times Cited: 22
Studies Regarding the Pharmaceutical Potential of Derivative Products from Plantain
Marilena-Gabriela Olteanu Zaharie, Nicoleta Radu, Lucia Pîrvu, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1827-1827
Open Access | Times Cited: 15
Cell-free Lactiplantibacillus plantarum OC01 supernatant suppresses IL-6-induced proliferation and invasion of human colorectal cancer cells: Effect on β-Catenin degradation and induction of autophagy
Letizia Vallino, Beatrice Garavaglia, Annalisa Visciglia, et al.
Journal of Traditional and Complementary Medicine (2023) Vol. 13, Iss. 2, pp. 193-206
Open Access | Times Cited: 8
Natural products modulate cell apoptosis: a promising way for treating endometrial cancer
Xin Zhou, Yiwei Zeng, Runchen Zheng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Hypoxia-induced miR-9 expression promotes ovarian cancer progression via activating PI3K/AKT/mTOR/GSK3β signaling pathway
Wenjing Zhu, Huanhuan Huang, Yifan Feng, et al.
Neoplasma (2023) Vol. 70, Iss. 02, pp. 216-228
Open Access | Times Cited: 7
Metabolite Profiling of Colvillea racemosa via UPLC-ESI-QTOF-MS Analysis in Correlation to the In Vitro Antioxidant and Cytotoxic Potential against A549 Non-Small Cell Lung Cancer Cell Line
Álvaro Fernández‐Ochoa, Inas Y. Younis, Reem K. Arafa, et al.
Plants (2024) Vol. 13, Iss. 7, pp. 976-976
Open Access | Times Cited: 2
A bibliometric analysis of the application of the PI3K-AKT-mTOR signaling pathway in cancer
Zhengzheng Deng, Qiancheng Qing, Bo Huang
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7255-7272
Closed Access | Times Cited: 2
FKBP4 Accelerates Malignant Progression of Non-Small-Cell Lung Cancer by Activating the Akt/mTOR Signaling Pathway
Wen Meng, Jingfei Meng, Hong Jiang, et al.
Analytical Cellular Pathology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 21
Melatonin and inflammatory bowel disease: From basic mechanisms to clinical application
Mostafa Vaghari‐Tabari, Soheila Moein, Ali Alipourian, et al.
Biochimie (2022) Vol. 209, pp. 20-36
Closed Access | Times Cited: 13
Polyphenol‐Based Nanosystems for Next‐Generation Cancer Therapy: Multifunctionality, Design, and Challenges
Chenqian Feng, Bo Chen, Rangrang Fan, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 11
Closed Access | Times Cited: 7
Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment
Qiushuang Wu, Janet Pik Ching Wong, Hang Fai Kwok
Cells (2020) Vol. 9, Iss. 5, pp. 1213-1213
Open Access | Times Cited: 20
Melatonin: An atypical hormone with major functions in the regulation of angiogenesis
Mohammad Mirza‐Aghazadeh‐Attari, Rüssel J. Reiter, Reza Rikhtegar, et al.
IUBMB Life (2020) Vol. 72, Iss. 8, pp. 1560-1584
Open Access | Times Cited: 19
Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment
Arunaksharan Narayanankutty
Recent Patents on Anti-Cancer Drug Discovery (2020) Vol. 15, Iss. 3, pp. 188-199
Closed Access | Times Cited: 18
MicroRNAs involved in the EGFR pathway in glioblastoma
Bin Xu, Jie Mei, Wei Ji, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 134, pp. 111115-111115
Open Access | Times Cited: 18
Investigation of the combined cytotoxicity induced by sodium butyrate and a flavonoid quercetin treatment on MCF-7 breast cancer cells
Zeynep Betts, Asuman Deveci Özkan, Burcu Yüksel, et al.
Journal of Toxicology and Environmental Health (2023) Vol. 86, Iss. 22, pp. 833-845
Closed Access | Times Cited: 5
RETRACTED ARTICLE: Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway
Peng Wang, Yuanjing Hu, Pengpeng Qu, et al.
Bioengineered (2022) Vol. 13, Iss. 1, pp. 1931-1941
Open Access | Times Cited: 9
Targeting mTOR Signaling by Dietary Polysaccharides in Cancer Prevention: Advances and Challenges
Mengyuan Li, Zuomin Hu, Tianyi Guo, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 71, Iss. 1, pp. 96-109
Closed Access | Times Cited: 8
Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers
Zhi-Chao Min, Yuanyuan Mi, Zhiwei Lv, et al.
Disease Markers (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 7
Thymoquinone Potentiates Methotrexate Mediated-Apoptosis in Saos-2 Osteosarcoma Cell Line
Payam Ali khyavi, Amir Valizadeh, Dariush Shanehbandi, et al.
Drug Research (2022) Vol. 72, Iss. 07, pp. 390-395
Closed Access | Times Cited: 7

Scroll to top